23andMe Holding Co. (MEHCQ)
OTCMKTS
· Delayed Price · Currency is USD
3.300
-0.080 (-2.37%)
May 23, 2025, 9:30 AM EDT
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $88.53 million as of May 27, 2025. Its market cap has decreased by -62.02% in one year.
Market Cap
88.53M
Enterprise Value
69.72M
Revenue
208.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.30
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from 622.97M to 88.53M, a decrease of -85.79%. That is a compound annual growth rate of -35.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 88.53M | 5.43% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 1.63B |
| Veradigm | 747.23M |
| Nika Pharmaceuticals | 672.83M |
| Tian'an Technology Group | 591.73M |
| Elite Pharmaceuticals | 565.54M |
| Glass House Brands | 452.21M |
| CytoDyn | 423.89M |
| Northwest Biotherapeutics | 399.66M |